Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : AMGN    crawled time : 20:08    save search
Amgen's Investigational KRAS G12C Inhibitor Sotorasib Demonstrated Rapid, Deep And Durable Responses In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
Published: 2021-01-28 (Crawled : 20:08) - prnewswire.com
AMGN | News | $272.245 0.12% 220K twitter stocktwits trandingview |
Health Technology
 | | O: -1.14% H: 0.63% C: -1.43%
cancer ev lung cancer
Gainers vs Losers
89% 11%

Top 10 Gainers
MTTR | News M | $4.65 167.24% 9.8M twitter stocktwits trandingview |

AGBA | $2.355 88.4% 34M twitter stocktwits trandingview |
Finance
EDBL | News | $6.94 84.57% 1.4M twitter stocktwits trandingview |

CZOO | $8.77 75.75% 11M twitter stocktwits trandingview |

VNRX | $0.84 40.0% 2.6M twitter stocktwits trandingview |
Health Technology
OPRT | News | $3.01 33.78% 6.8M twitter stocktwits trandingview |
Finance
MLEC | $1.81 29.29% 2M twitter stocktwits trandingview |
n/a
CMAX | $4.12 28.35% 65K twitter stocktwits trandingview |
Manufacturing
MTC | $2.0 28.21% 1.7M twitter stocktwits trandingview |
Technology Services
PEGY | $0.0586 27.95% 130M twitter stocktwits trandingview |
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.